✦ LIBER ✦

High-dose CEF (cyclophosphamide, epirubicin, fluorouracil) as primary chemotherapy in locally advanced breast cancer: Long term survival data

✍ Scribed by F. Conti; P. Perri; I. Sperduti; A. Amodio; S. Carpano; P. Foggi; M. Anzà; M. Della Giulia; M. Lopez

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel and high-dose epirubicin as ne

✍ E. Espinosa; S. Morales; P. Borrega; A. Casas; C. Madroñal; I. Machengs; J. A. I 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 208 KB

Cyclophosphamide, epirubicin, high-dose

✍ Zaniboni, Alberto; Simoncini, Edda; Marpicati, Patrizia; Montini, Elisabetta; Fe 📂 Article 📅 1989 🏛 Elsevier Science ⚖ 553 KB

P84 High dose epirubicin and cyclophosph

✍ E. Galligioni; G. Cetto; O. Nascimben; A. Buonadonna; D. Crivellari; A. Molino; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Long-Term Survival after High-Dose Chemo

✍ VanderWalde, A.; Ye, W.; Frankel, P.; Asuncion, D.; Leong, L.; Luu, T.; Morgan, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 214 KB

An EORTC phase I study of epirubicin in

✍ H Bonnefoi; L Biganzoli; T Cufer; L Mauriac; A Hamilton; P Schaefer; M Piccart 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 90 KB

Final Results of a Randomized Phase III

✍ Therasse, P. 📂 Article 📅 2003 🏛 American Society of Clinical Oncology 🌐 English ⚖ 107 KB